- Associated Press - Wednesday, September 24, 2014

ALBUQUERQUE, N.M. (AP) - A New Mexico company that markets diagnostic tests for lupus and other autoimmune rheumatoid diseases has filed for an initial public offering.

The Albuquerque Journal reports (https://goo.gl/gYe4Mf) that Exagen Diagnostics Inc. recently filed its registration statement with the U.S. Securities and Exchange Commission.

Exagen President and CEO Ron Rocca says the Albuquerque company has to wait for about three weeks and then officials will visit with bankers and investors.

Exagen uses software to identify key genomic biomarkers to diagnose and treat disease. It released its first lupus test in January 2012.

Launched in 2002, the company has raised about $40 million in venture capital, including about $6 million from Sun Mountain Capital in Santa Fe.

___

Information from: Albuquerque Journal, https://www.abqjournal.com

Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times is switching its third-party commenting system from Disqus to Spot.IM. You will need to either create an account with Spot.im or if you wish to use your Disqus account look under the Conversation for the link "Have a Disqus Account?". Please read our Comment Policy before commenting.

 

Click to Read More

Click to Hide